Few comments from Platypus AM from their latest monthly report...

  1. 4,705 Posts.
    lightbulb Created with Sketch. 72
    Few comments from Platypus AM from their latest monthly report for March

    "Turnover was a touch over 11% in March as we initiated new positions in Acrux and IOOF Holdings, and bought back Myer and ALS Ltd. Acrux has licensed their testosterone product to Eli Lily, which is once again starting to take market share from incumbent treatments."

    http://www.platypusassetmanagement.com.au/performance/performance.html



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.001(2.78%)
Mkt cap ! $7.543M
Open High Low Value Volume
1.8¢ 1.9¢ 1.8¢ $3.047K 167.8K

Buyers (Bids)

No. Vol. Price($)
2 175000 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 697115 4
View Market Depth
Last trade - 11.22am 24/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.